Crossmark Global Holdings Inc. Has $14.50 Million Holdings in Amgen, Inc.


Crossmark Global Holdings Inc. trimmed its position in shares of Amgen, Inc. by 7.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 69,926 shares of the medical research company's stock after selling 5,346 shares during the quarter.



from Biotech News